The Dark Side of Genetic Therapy

At that age, gene therapy has advanced, but further progress is needed. On the surface, almost all clinical trials performed were unsuccessful. There are many reasons for this. It includes media, investors, and snap tests. Because biotechnology is a serious science field, studies and research should not be rushed and may exceed valuable information. But the reality gave another highlight, the test was in a hurry, and the failure had already led.

Genetics-based treatment: Genetic-based treatment has made a further leap in promoting human health. There are many ways to classify genetic treatments. Genome editing, stem cell gene therapy, genetic age research and so on. As more data comes from genetically based 'consumer diagnosis', more genetic differences in clarifying things can affect our medical decisions it can.

Gene therapy is one of the most important advantages of human genetic engineering. Over the past decade, gene therapy has succeeded in finding ways to treat specific heart diseases. Researchers want to find ways to treat all hereditary diseases. This will lead to healthier and evolved people

The main development of genetic research is genetic engineering or gene therapy. Gene therapy inserts genetic material into foreign cells and revolutionizes the field of genetics. In the early nineteenth century, Canadian physiologists isolated hormones called insulin. Lack of insulin in the body can cause diabetes, it is a fatal disease. About 40 years later, scientists began looking for ways to replace the body's insulin. Scientists often use porcine insulin, but the body usually rejects foreign hormones. Scientists discovered how to inject human insulin DNA into porcine cells after a large-scale experiment in the 1970s to mix pig genes and human genes. This ultimately leads to a way to allow human insulin to grow in the laboratory using simple bacteria. Millions of people take insulin made by genetic research method everyday. (Lebovitz, paragraph 6)

Gene therapy is based on medical intervention to alter the genetic material of living cells. The cells can be modified ex vivo to be administered to humans or they can be modified in vivo by gene therapy administered directly to the subject. It is also a form of somatic cell therapy when genetic engineering is performed ex vivo on cells and then administered to a patient. Genetic manipulation can be intended to provide a therapeutic or prophylactic effect or it can provide a way to label cells for later identification. Recombinant DNA substances used to transfer genetic material for such treatment are considered part of gene therapy and are therefore subject to regulatory supervision.